Paula Traktman to Mutation
This is a "connection" page, showing publications Paula Traktman has written about Mutation.
Connection Strength
0.891
-
Structure-Function Analysis of Two Interacting Vaccinia Proteins That Are Critical for Viral Morphogenesis: L2 and A30.5. J Virol. 2022 01 26; 96(2):e0157721.
Score: 0.133
-
Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J Virol. 1995 Oct; 69(10):6581-7.
Score: 0.087
-
Biochemical analysis of mutant alleles of the vaccinia virus topoisomerase I carrying targeted substitutions in a highly conserved domain. J Biol Chem. 1993 Jul 25; 268(21):15887-99.
Score: 0.075
-
Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J Virol. 1992 Jul; 66(7):4413-26.
Score: 0.070
-
Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity. J Virol. 1991 Feb; 65(2):869-79.
Score: 0.063
-
Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J Virol. 1990 Feb; 64(2):574-83.
Score: 0.059
-
Biochemical and genetic analysis of the vaccinia virus d5 protein: Multimerization-dependent ATPase activity is required to support viral DNA replication. J Virol. 2007 Jan; 81(2):844-59.
Score: 0.047
-
The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell. 2006 May; 17(5):2451-64.
Score: 0.045
-
Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase. J Biol Chem. 2006 Feb 10; 281(6):3439-51.
Score: 0.044
-
Genetic and cell biological characterization of the vaccinia virus A30 and G7 phosphoproteins. J Virol. 2005 Jun; 79(11):7146-61.
Score: 0.043
-
Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions. J Virol. 2004 Aug; 78(16):8885-901.
Score: 0.040
-
Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase. J Virol. 2004 Feb; 78(4):1992-2005.
Score: 0.039
-
Protease bypass of temperature-sensitive murine leukemia virus maturation mutants. J Virol. 1982 Dec; 44(3):1039-46.
Score: 0.036
-
Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain. J Virol. 1993 Jul; 67(7):4323-36.
Score: 0.019
-
Characterization of vaccinia virus DNA replication mutants with lesions in the D5 gene. Chromosoma. 1992; 102(1 Suppl):S72-82.
Score: 0.017
-
Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression. J Virol. 1992 Jan; 66(1):534-47.
Score: 0.017
-
Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 1990 Jun; 9(6):1805-13.
Score: 0.015
-
The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science. 1990 Jan 12; 247(4939):209-12.
Score: 0.015
-
Genetic evidence for involvement of vaccinia virus DNA-dependent ATPase I in intermediate and late gene expression. J Virol. 1989 Sep; 63(9):3999-4010.
Score: 0.014
-
Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication. J Virol. 1987 Oct; 61(10):3152-62.
Score: 0.013
-
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol. 1981 Apr; 38(1):239-48.
Score: 0.002